Silence Therapeutics Stock: A Speculative Buy (NASDAQ:SLN)

DNA strands

Evgenii Kovalev

Background

Silence Therapeutics (NASDAQ:SLN) is a UK-based biotechnology company specializing in RNA interference [RNAi] technology. The company is focused on developing and commercializing a pipeline of therapies using its proprietary platform technology to target and silence disease-causing genes. Silence Therapeutics has a

Read more here: Source link